A Health Podyssey

Listen to Alan Weil interview Dr. Angela Shen, visiting scientist at the Children's Hospital of Philadelphia, on equitable access to a COVID-19 vaccine once it's available.

Show Notes

Looking to drive meaningful change in the health care ecosystem? Look to the Deloitte Health Equity Institute.

In November, the pharma companies Pfizer and Moderna both announced substantial progress on a potential COVID-19 vaccine. While both vaccines showed promising results during clinical trials, questions remain for what's next and how to distribute a vaccine once it's available for public use.

One major question mark concerns logistics. For example, the Pfizer vaccine needs to be kept at extremely cold temperatures while traveling through the supply chain — though that doesn't seem to be the case for Moderna's vaccine.

Another worry is ensuring equitable access to an effective vaccine. Dr. Angela Shen, visiting scientist at the Children's Hospital of Philadelphia and vaccine policy expert, recently published a paper on the topic in a special cluster on COVID-19 vaccines in Health Affairs. She joins A Health Podyssey to discuss her paper, as well as the challenges and opportunities the US will face to secure equitable access to a COVID-19 vaccine.

Subscribe: RSS | Apple Podcasts | Google Podcasts | Spotify | Castro | Stitcher

What is A Health Podyssey?

Each week, Health Affairs Editor-in-Chief Alan Weil brings you in-depth conversations with leading researchers and influencers shaping the big ideas in health policy and the health care industry.

A Health Podyssey goes beyond the pages of the health policy journal Health Affairs to tell stories behind the research and share policy implications. Learn how academics and economists frame their research questions and journey to the intersection of health, health care, and policy. Health policy nerds rejoice! This podcast is for you.